• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    12/6/23 2:43:02 PM ET
    $AAOI
    $ALLR
    $ALT
    $ARVN
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAOI alert in real time by email

    Shares of AeroVironment, Inc. (NASDAQ:AVAV) moved lower during Wednesday’s session following second-quarter results.

    AeroVironment posted adjusted earnings of 97 cents per shares, beating analysts’ estimates of 62 cents per share. The company’s revenue came in at $180.8 million beating estimates of $170.908 million.

    AeroVironment shares dipped 9.2% to $128.42 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Sera Prognostics, Inc. (NASDAQ:SERA) shares jumped 113.4% to $4.63 after the company announced the DSMB overseeing its PRIME study recommended stopping enrollment due to efficacy.
    • MicroAlgo Inc. (NASDAQ:MLGO) gained 61.2% to $3.90 after the company announced it plans to establish a postgraduate training practice base.
    • Phio Pharmaceuticals Corp. (NASDAQ:PHIO) shares climbed 37.5% to $1.54.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) gained 37% to $1.30 following H1 results.
    • Leju Holdings Limited (NYSE:LEJU) gained 37% to $1.8362.
    • Pharvaris N.V. (NASDAQ:PHVS) shares climbed 33.7% to $28.00 after the company announced the CHAPTER-1 Phase 2 clinical study met its primary endpoint.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) shares gained 32.6% to $0.3048 after the company announced it raised $2.5 million in debt financing.
    • Webuy Global Ltd (NASDAQ:WBUY) jumped 32.4% to $7.88 after the company announced it entered into a non-binding MOU to acquire controlling interest in PT. Tiga Sakti Utama.
    • Chanson International Holding (NASDAQ:CHSN) climbed 28.2% to $6.10.
    • Cano Health, Inc. (NYSE:CANO) climbed 28% to $12.11.
    • Phreesia, Inc. (NYSE:PHR) gained 23.5% to $18.23 following third-quarter results.
    • Reliance Global Group, Inc. (NASDAQ:RELI) rose 22.7% to $0.9679.
    • Clean Earth Acquisitions Corp. (NASDAQ:CLIN) shares gained 22.6% to $7.53 after falling over 3% on Tuesday.
    • Arvinas, Inc. (NYSE:ARVN) rose 21.7% to $28.20. Arvinas and Pfizer released clinical data for vepdegestrant (ARV-471) in combination with palbociclib (IBRANCE).
    • Mesa Air Group, Inc. (NASDAQ:MESA) climbed 19.5% to $1.17. Mesa Air Group is expected to release its 2023 fourth quarter earnings after the closing bell on Thursday, Dec. 14.
    • Altimmune, Inc. (NASDAQ:ALT) jumped 18.4% to $6.13.
    • SentinelOne, Inc. (NYSE:S) gained 17.4% to $23.48 after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) surged 13.2% to $16.21.
    • The Lovesac Company (NASDAQ:LOVE) rose 12.1% to $23.56 following quarterly results.
    • Aspen Aerogels, Inc. (NYSE:ASPN) shares climbed 12% to $11.93. Aspen Aerogels reported additional EV Thermal barrier commercial award and issued an update on U.S. Department of Energy loan application status.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 12% to $18.09. Applied Optoelectronics recently announced a proposed private offering of $80 million of convertible senior notes due 2026.
    • Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) gained 10.2% to $46.22 following quarterly results.
    • Avis Budget Group, Inc. (NASDAQ:CAR) gained 9.2% to $200.80. Avis Budget declared a special cash dividend of $10.00 per share of common stock.

    Losers

    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) fell 36.2% to $0.7215 after declining 24% on Tuesday. The company announced that it met its primary safety, tolerability and secondary clinical efficacy endpoints in its Phase 2b PARADIGM Trial of PrimeC in ALS.
    • ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) shares dipped 32.5% to $1.0401 after the company announced pricing of a $1.1 million public offering of common shares.
    • Volato Group, Inc. (NYSE:SOAR) fell 24.7% to $7.52.
    • OptiNose, Inc. (NASDAQ:OPTN) fell 23.8% to $1.12 after the company announced a three-month extension of the FDA review period for the supplemental new drug application for XHANCE as a treatment for chronic rhinosinusitis.
    • Nvni Group Limited (NASDAQ:NVNI) declined 20.4% to $1.3603.
    • Yext, Inc. (NYSE:YEXT) shares fell 19.3% to $5.66 after the company reported third-quarter financial results and issued guidance.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 19.2% to $0.5397 following third-quarter results.
    • Chijet Motor Company, Inc. (NASDAQ:CJET) declined 16.2% to $0.8299.
    • Asana, Inc. (NYSE:ASAN) shares fell 15.2% to $19.77. Asana posted upbeat results for its third quarter and issued a strong forecast for FY24.
    • Cazoo Group Ltd (NYSE:CZOO) declined 14.1% to $34.78. Cazoo Group announced methodology update for $630 million convertible notes exchange.
    • Fluence Energy, Inc. (NASDAQ:FLNC) shares fell 13% to $22.40 after the company announced a secondary offering of Class A common stock by existing controlling stockholders.
    • XBP Europe Holdings, Inc. (NASDAQ:XBP) declined 11.9% to $31.01.
    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) declined 11.3% to $5.43.
    • Janover Inc. (NASDAQ:JNVR) fell 10.6% to $1.43 after surging 38% on Tuesday.
    • Brown-Forman Corporation (NYSE: BF-B) fell 10.3% to $54.02 following quarterly results.
    • Powell Industries, Inc. (NASDAQ:POWL) declined 10.3% to $79.25 following fourth-quarter results.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares fell 10.3% to $0.5197. Allarity recently announced initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of stenoparib in women with advanced ovarian cancer.
    • Box, Inc. (NYSE:BOX) fell 9.2% to $24.24 after the company reported worse-than-expected third-quarter financial results and issued FY24 guidance below estimates.
    • British American Tobacco p.l.c. (NYSE:BTI) shares declined 8.3% to $28.93 after it reported a pre-close trading update. BAT expects to incur an accounting non-cash adjusting impairment charge relating to some U.S. cigarette brands of around £25 billion ($31.50 billion).
    • Stitch Fix, Inc. (NASDAQ:SFIX) fell 8.1% to $3.5550 following quarterly results.
    • MongoDB, Inc. (NASDAQ:MDB) shares fell 7.3% to $402.04 after the company reported third-quarter financial results.

     

    Now Read This: Bitcoin Jumps To $44,000 Following ADP Data; BitTorrent Emerges As Top Gainer

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ALLR
    $ALT
    $ARVN

    CompanyDatePrice TargetRatingAnalyst
    Box Inc.
    $BOX
    3/23/2026Outperform → Mkt Perform
    William Blair
    MongoDB Inc.
    $MDB
    3/23/2026$325.00Neutral → Outperform
    Mizuho
    AeroVironment Inc.
    $AVAV
    3/23/2026Underperform → Mkt Perform
    Raymond James
    Fluence Energy Inc.
    $FLNC
    3/20/2026Hold
    Needham
    Fluence Energy Inc.
    $FLNC
    3/19/2026Sell → Neutral
    Guggenheim
    Altimmune Inc.
    $ALT
    3/18/2026$12.00Buy
    Truist
    Yext Inc.
    $YEXT
    3/11/2026$6.00Buy → Neutral
    Roth Capital
    AeroVironment Inc.
    $AVAV
    3/11/2026$450.00 → $400.00Buy
    Needham
    More analyst ratings

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pineiro Antonio

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    3/27/26 7:53:46 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Klohn Steve

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    3/27/26 7:50:44 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Gandhi Balaji

    4 - Phreesia, Inc. (0001412408) (Issuer)

    3/27/26 5:21:15 PM ET
    $PHR
    Real Estate

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Box downgraded by William Blair

    William Blair downgraded Box from Outperform to Mkt Perform

    3/23/26 8:25:07 AM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    MongoDB upgraded by Mizuho with a new price target

    Mizuho upgraded MongoDB from Neutral to Outperform and set a new price target of $325.00

    3/23/26 8:23:30 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    AeroVironment upgraded by Raymond James

    Raymond James upgraded AeroVironment from Underperform to Mkt Perform

    3/23/26 8:22:28 AM ET
    $AVAV
    Aerospace
    Industrials

    $AAOI
    $ALLR
    $ALT
    $ARVN
    SEC Filings

    View All

    SEC Form 8-K filed by Avis Budget Group Inc.

    8-K - AVIS BUDGET GROUP, INC. (0000723612) (Filer)

    3/27/26 5:25:20 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    SEC Form 424B5 filed by Avis Budget Group Inc.

    424B5 - AVIS BUDGET GROUP, INC. (0000723612) (Filer)

    3/27/26 5:06:44 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    SEC Form DEFA14A filed by Aspen Aerogels Inc.

    DEFA14A - ASPEN AEROGELS INC (0001145986) (Filer)

    3/27/26 5:02:16 PM ET
    $ASPN
    RETAIL: Building Materials
    Consumer Discretionary

    $AAOI
    $ALLR
    $ALT
    $ARVN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Morrison Briggs bought $268,070 worth of shares (20,000 units at $13.40), increasing direct ownership by 26% to 96,021 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    3/9/26 4:05:21 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Lovesac Company Expands Share Repurchase Authorization by $40 Million

    STAMFORD, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (NASDAQ:LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand, today announced that its Board of Directors has authorized the repurchase of up to an additional $40 million of the Company's outstanding common stock, expanding its existing share repurchase program to approximately $54.1 million. Keith Siegner, Executive Vice President and Chief Financial Officer, stated, "We are pleased to announce the expansion of our share repurchase program, reflecting strong confidence in our business outlook. With a healthy balance sheet, access to meaningful liquidity through our credit facility, and

    3/26/26 7:01:00 AM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    The Lovesac Company Reports Fourth Quarter and Fiscal 2026 Financial Results

    Q4 FY26 Net Sales Increased 2.7% to $248.0 million vs. Q4 FY25 FY26 Net Sales Increased 2.4% to $697.1 million vs. FY25Announces New $40 million Share Repurchase Authorization STAMFORD, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (NASDAQ:LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the fourth quarter and full year fiscal 2026, which ended February 1, 2026. Shawn Nelson, Chief Executive Officer, stated, "Fiscal 2026 was a pivotal year for Lovesac. We made substantial progress on our evolution from a product-driven company into a mu

    3/26/26 7:00:00 AM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    State and Local Governments Turn to Box to Modernize Workflows with Secure AI

    Box's State and Local Government Summit spotlights public-sector use cases, demonstrating secure, compliant AI-powered content management Box, Inc. (NYSE:BOX), the leading Intelligent Content Management (ICM) platform, today highlighted how state and local governments are transforming operations with secure, AI-powered content at its annual State and Local Government Virtual Summit. The summit featured speakers from the City and County of Denver, who shared how they are using Box as an AI-powered content management platform to modernize case workflows and deliver faster, more secure, and more responsive public services, alongside Box executives including CEO and co-founder Aaron Levie.

    3/25/26 12:30:00 PM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Financials

    Live finance-specific insights

    View All

    The Lovesac Company Reports Fourth Quarter and Fiscal 2026 Financial Results

    Q4 FY26 Net Sales Increased 2.7% to $248.0 million vs. Q4 FY25 FY26 Net Sales Increased 2.4% to $697.1 million vs. FY25Announces New $40 million Share Repurchase Authorization STAMFORD, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (NASDAQ:LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced financial results for the fourth quarter and full year fiscal 2026, which ended February 1, 2026. Shawn Nelson, Chief Executive Officer, stated, "Fiscal 2026 was a pivotal year for Lovesac. We made substantial progress on our evolution from a product-driven company into a mu

    3/26/26 7:00:00 AM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    Rent the Runway to Report Fourth Quarter and Fiscal Year 2025 Results on April 14, 2026

    NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. ("Rent the Runway") (NASDAQ:RENT) announced today that it expects to release its fourth quarter and fiscal year 2025 financial results for the quarter and year ended January 31, 2026 on Tuesday, April 14, 2026, before market open. Rent the Runway will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time that same day to discuss its results and to provide a business update. The financial results and live webcast, including presentation materials, will be accessible through the Investor Relations section of Rent the Runway's website at https://investors.renttherunway.com/ under the

    3/24/26 4:01:00 PM ET
    $RENT
    Other Specialty Stores
    Consumer Discretionary

    Dave & Buster's Entertainment, Inc. to Report Fourth Quarter and Fiscal Year End 2025 Financial Results on March 31, 2026

    DALLAS, March 17, 2026 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner, operator, and franchisor of entertainment and dining venues, today announced that it will report financial results for its fourth quarter and fiscal year ended February 3, 2026 after the market closes on Tuesday, March 31, 2026. Management will host a conference call to discuss these results on Tuesday, March 31, 2026, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). A live and archived webcast of the conference call will be available under the Investor Relations section of the Company's website at ir.daveandbusters.com. Additionally, participan

    3/17/26 4:05:00 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by OptiNose Inc.

    SC 13G - OptiNose, Inc. (0001494650) (Subject)

    11/20/24 5:21:26 PM ET
    $OPTN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ALLR
    $ALT
    $ARVN
    Leadership Updates

    Live Leadership Updates

    View All

    MongoDB Appoints Ryan Mac Ban as Chief Revenue Officer to Support Next Phase of Growth

    NEW YORK, March 24, 2026 /PRNewswire/ -- MongoDB (NASDAQ:MDB) today announced the appointment of Ryan Mac Ban as Chief Revenue Officer (CRO), effective April 27, 2026. Reporting to President and Chief Executive Officer (CEO) CJ Desai, Mac Ban will lead MongoDB's global sales team. Following the recent appointment of Erica Volini as Chief Customer Officer, Mac Ban's arrival further strengthens MongoDB's go-to-market leadership team as the company enters its next phase of growth. "This is an important moment for MongoDB. Ryan brings deep experience leading global organizations thr

    3/24/26 8:50:00 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    SentinelOne Names Barry Padgett to President & Chief Operating Officer

    Promotion and expanded leadership role follow Padgett's successful tenure as SentinelOne's Chief Growth Officer and Interim Chief Financial Officer SentinelOne® (NYSE:S), the AI Security leader, today announced the appointment of Barry Padgett as President and Chief Operating Officer (COO), effective immediately. The promotion follows Padgett's successful tenure as the company's Chief Growth Officer and his recent role as interim Chief Financial Officer (CFO). This transition aligns with Sonalee Parekh officially starting her role as the company's new CFO, as announced earlier this month. In his elevated role as President and COO, Padgett will take on an expanded mandate, focusing on co

    3/24/26 8:30:00 AM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Phreesia and Sesame Workshop Win Point of Care Excellence Award for Best Unbranded Campaign

    Phreesia, a leader in patient intake, outreach and activation, and Sesame Workshop, the global nonprofit behind Sesame Street, received the Point of Care Excellence Award for their pediatric health and wellness campaign. The award, announced at the Point of Care Marketing Association's (POCMA) POC Now Summit on March 18, recognizes outstanding campaigns, strategies, and individuals advancing patient and HCP engagement through innovative point-of-care (POC) marketing. The two organizations announced a five-year collaboration in August 2025, and in October launched a six-part campaign to engage millions of parents and caregivers with educational and entertaining messages to help keep thei

    3/19/26 9:03:00 PM ET
    $PHR
    Real Estate